Ironwood Pharmaceuticals
IRWD
IRWD
199 hedge funds and large institutions have $1.95B invested in Ironwood Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 67 increasing their positions, 61 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 190 → 199 (+9)
10% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 61
0.25% less ownership
Funds ownership: 107.46% → 107.21% (-0.25%)
Holders
199
Holding in Top 10
3
Calls
$15.9M
Puts
$6.56M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$14.3M | |
| 3 | +$12.4M | |
| 4 |
Goldman Sachs
New York
|
+$12M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$10.9M |
Top Sellers
| 1 | -$30.5M | |
| 2 | -$28.9M | |
| 3 | -$11.9M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$11.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.96M |